These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15994648)

  • 1. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Barad DH
    Obstet Gynecol; 2005 Jul; 106(1):196-7; author reply 197. PubMed ID: 15994648
    [No Abstract]   [Full Text] [Related]  

  • 2. Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?
    Homburg R; Meltcer S; Rabinson J; Zohav E; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1311-3. PubMed ID: 18384783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization.
    Klinkert ER; Broekmans FJ; Looman CW; Habbema JD; te Velde ER
    Fertil Steril; 2005 Mar; 83(3):811-4. PubMed ID: 15749527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Fertil Steril; 2009 Apr; 91(4 Suppl):1553-5. PubMed ID: 19217095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antral follicle count is a significant predictor of livebirth in in vitro fertilization cycles.
    Maseelall PB; Hernandez-Rey AE; Oh C; Maagdenberg T; McCulloh DH; McGovern PG
    Fertil Steril; 2009 Apr; 91(4 Suppl):1595-7. PubMed ID: 19100533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
    Letterie GS; Lee JS; Padmanabhan V
    Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome'.
    Klinkert E; te Velde E; Broekmans F
    Hum Reprod; 2005 Feb; 20(2):573; author reply 573-4. PubMed ID: 15670974
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
    Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
    Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
    Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
    Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.